Frank C. Schlichtenbrede

AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa

Alexander J. Smith, Frank C. Schlichtenbrede, Marion Tschernutter et al. · Molecular Therapy · 2003 · 137 citations · Full text

Ocular Disease, Molecular Biology, Pathology +19

Intravitreal Bevacizumab for Retinopathy of Prematurity: Refractive Error Results

Björn C. Harder, Frank C. Schlichtenbrede, Stefan von Baltz et al. · American Journal of Ophthalmology · 2013 · 134 citations

Ocular Disease, Vitreous Body, Experimental Ophthalmology +2

Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration

Frank C. Schlichtenbrede, Alex MacNeil, James Bainbridge et al. · Gene Therapy · 2003 · 132 citations · Full text

Ocular Disease, Photoreceptor Cell, Retina +12

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Marion Tschernutter, Frank C. Schlichtenbrede, Steven J. Howe et al. · Gene Therapy · 2005 · 127 citations

Ocular Disease, Retina, Rcs Rat Model +9

Short-term complications of intravitreal injections of triamcinolone and bevacizumab

Jost B. Jonas, U.H. Spandau, Frank C. Schlichtenbrede · Eye · 2008 · 106 citations · Full text

Short-term Complications, Minimally Invasive Procedure, Pharmacotherapy +2